| Literature DB >> 34527432 |
Chonticha Romyasamit1, Phoomjai Sornsenee2, Siriphorn Chimplee3, Sitanun Yuwalaksanakun1, Dechawat Wongprot1, Phanvasri Saengsuwan3.
Abstract
BACKGROUND: The increasing prevalence of broad-spectrum ampicillin-resistant and third-generation cephalosporin-resistant Enterobacteriaceae, particularly Escherichia coli and Klebsiella pneumoniae, has become a global concern, with its clinical impacts on both human and veterinary medicine. This study examined the prevalence, antimicrobial susceptibility, and molecular genetic features of extended-spectrum β-lactamase (ESBL)-producing E. coli and K. pneumoniae isolates from 10 types of raw vegetables.Entities:
Keywords: Antibiotic resistance; ESBL-producing bacteria; Escherichia coli; Klebsiella pneumoniae; Vegetables
Year: 2021 PMID: 34527432 PMCID: PMC8401748 DOI: 10.7717/peerj.11787
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
PCR primer designs and their conditions for gene amplifications.
|
|
|
|
|
|
|
|
| |||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |||
|
|
| Ctxm1-115F | GAATTAGAGCGGCAGTCGGG | 588 | 95 | 30 | 60 | 90 | 72 | 90 |
| Ctxm1-702R | CACAACCCAGGAAGCAGGC | |||||||||
|
|
| Ctxm9-16F | GTGCAACGGATGATGTTCGC | 475 | ||||||
| Ctxm9-490R | GAAACGTCTCATCGCCGATC | |||||||||
|
|
| TEM-164.SE | TCGCCGCATACACTATTCTCAGAATGA | 445 | ||||||
| TEM-165.AS | ACGCTCACCGGCTCCAGATTTAT | |||||||||
|
|
| SHV.SE | ATGCGTTATATTCGCCTGTG | 747 | 94 | 30 | 60 | 40 | 72 | 90 |
| SHV.AS | TGCTTTGTTATTCGGGCCAA | |||||||||
|
|
| GES-F | TAC TGG CAG SGA TCG CTC AC | 838 | 62 | 90 | ||||
| GES-F | TTG TCC GTG CTC AGG ATG AG | |||||||||
|
|
| VEB-F | GCC AGA ATA GGA GTA GCA AT | 703 | 96 | 30 | 58 | 90 | 72 | 30 |
| VEB-R | TGG ACT CTG CAA CAA ATA CG | |||||||||
|
|
| PER-F | CTC AGC GCA ATC CCC ACT GT | 851 | 62 | 90 | ||||
| PER-R | TTG GGC TTA GGG CAG AAA GCT | |||||||||
Summary of the raw vegetables and Prevalence of ESBL-producing E. coli and K. pneumoniae isolated from raw vegetables in retail markets in Mueang and Tha Sala districts, Nakhon Si Thammarat, Thailand.
|
|
|
|
| ||
|---|---|---|---|---|---|
|
|
|
|
|
|
|
| A | Thai yardlong beans | 34 | 1 (2.9) | 2 (5.9) | 3 (8.8) |
| B | Thai eggplant | 44 | 0 | 1 (2.3) | 1 (2.3) |
| C | Winged beans | 25 | 1 (4.0) | 1 (4.0) | 2 (8.0) |
| D | Young cashew leaves | 20 | 0 | 0 | 0 |
| E | Thai basil | 36 | 2 (5.6) | 1 (2.8) | 3 (8.3) |
| F | Cabbage | 21 | 0 | 0 | 0 |
| G | Cucumber | 36 | 1 (2.8) | 1 (2.8) | 2 (5.6) |
| H | Tomato | 31 | 0 | 2 (6.5) | 2 (6.5) |
| I | Long coriander | 32 | 0 | 1 (3.1) | 1 (3.1) |
| J | Lettuce | 26 | 0 | 0 | 0 |
| Total | 305 | 5 (1.6 | 9 (3.0 | 14 (4.6) | |
Notes.
extended-spectrum β-lactamase
E. coli
K. pneumoniae
Summary of the retail markets and Prevalence of ESBL-producing E. coli and K. pneumoniae isolated from raw vegetables in retail markets in Mueang and Tha Sala districts, Nakhon Si Thammarat, Thailand.
|
|
|
|
| ||
|---|---|---|---|---|---|
|
|
|
|
|
|
|
| 1 | Mor Chuan Fresh Market (Tha Sala M1) | 8 | 0 | 0 | 0 |
| 2 | Nab Anusorn Fresh Market (Tha Sala M2) | 38 | 1 (2.6) | 1 (2.6) | 2 (5.3) |
| 3 | Wat Node Market (Tha Sala M3) | 58 | 2 (3.5) | 1 (1.7) | 3 (5.2) |
| 4 | Thursday Flea Market (Tha Sala M4) | 53 | 0 | 0 | 0 |
| 5 | Sunday Flea market (Tha Sala M5) | 38 | 1 (2.6) | 0 | 1 (2.6) |
| 6 | Thapae Fresh Market (Mueang M1) | 42 | 1 (2.4) | 0 | 1 (2.4) |
| 7 | Khu Khwang Municipal Market (Mueang M2) | 21 | 0 | 4 (19.0) | 4 (19.0) |
| 8 | Tha Ma Fresh Market (Mueang M3) | 37 | 0 | 2 (5.4) | 2 (5.4) |
| 9 | Hua It Fresh Market (Mueang M4) | 10 | 0 | 1 (10.0) | 1 (10.0) |
| Total | 305 | 5 (1.6 | 9 (3.0 | 14 (4.6) | |
Notes.
extended-spectrum β-lactamase
E. coli
K. pneumoniae
Antimicrobial susceptibility test in ESBL-producing E.coli and K.pneumoniae.
|
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| Targeted β-lactam ring | Aminopenicillin | Ampicillin (AMP) | 12 (85.71) | 2 (14.29) | 0 | 3 (60) | 2 (40) | 0 | 9 (100) | 0 | 0 |
| Carbapenem | Imipenem (IPM) | 0 | 14 (100) | 0 | 0 | 5 (100) | 0 | 0 | 9 (100) | 0 | |
| Meropenem (MEM) | 3 (21.43) | 11 (78.57) | 0 | 3 (60) | 2 (40) | 0 | 0 | 9 (100) | 0 | ||
| Aztreonam (ATM) | 4 (28.57) | 10 (71.43) | 0 | 2 (40) | 3 (60) | 0 | 2 (22.22) | 7 (77.78) | 0 | ||
| Cephalosporin | Cefotaxime (CTX) | 9 (64.29) | 5 (35.71) | 0 | 5 (100) | 0 | 0 | 4 (44.44) | 5 (55.56) | 0 | |
| Ceftriaxone (CRO) | 5 (35.71) | 8 (57.14) | 1 (7.14) | 3 (60) | 2 (40) | 0 | 2 (22.22) | 6 (66.67) | 1 (11.11) | ||
| Ceftazidime (CAZ) | 9 (64.29) | 5 (35.71) | 0 | 5 (100) | 0 | 0 | 4 (44.44) | 5 (55.56) | 0 | ||
| Cefpodoxime (CPD) | 6 (42.86) | 7 (50.00) | 1 (7.14) | 2 (40) | 2 (40) | 1 (20) | 4 (44.44) | 5 (55.56) | 0 | ||
| Non targeted β-lactam ring | Aminoglycoside | Gentamycin (CN) | 2 (14.29) | 12 (85.71) | 0 | 0 | 5 (100) | 0 | 2 (22.22) | 7 (77.78) | 0 |
| Amikacin (AK) | 0 | 12 (85.71) | 2 (14.29) | 0 | 4 (80) | 1 (20) | 0 | 8 (88.89) | 1 (11.11) | ||
| Tetracycline | Tetracycline (TE) | 3 (21.43) | 11 (78.57) | 0 | 2 (40) | 3 (60) | 0 | 1 (11.11) | 8 (88.89) | 0 | |
Notes.
extended-spectrum β-lactamase
E. coli
K. pneumoniae
resistance
Susceptible
intermediate
Antimicrobial susceptibility test against ESBL-producing E. coli and K. pneumoniae isolates.
|
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
| |||||||||
|
|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| EC | |||||||||||
|
| R | S | R | S | R | R | R | R | S | S | R |
|
| R | S | R | R | R | S | R | S | S | S | S |
|
| S | S | S | R | R | R | R | R | S | S | S |
|
| R | S | R | S | R | S | R | S | S | S | R |
|
| S | S | S | S | R | R | R | I | S | I | S |
| KP | |||||||||||
|
| R | S | S | S | S | S | R | S | S | I | S |
|
| R | S | S | S | R | R | R | R | R | S | S |
|
| R | S | S | S | S | S | S | R | S | S | R |
|
| R | S | S | R | S | S | S | S | R | S | S |
|
| R | S | S | S | R | I | S | R | S | S | S |
|
| R | S | S | R | R | S | S | S | S | S | S |
|
| R | S | S | S | S | S | R | R | S | S | S |
|
| R | S | S | S | S | S | R | S | S | S | S |
|
| R | S | S | S | R | R | S | S | S | S | S |
Notes.
extended-spectrum β-lactamase
E. coli
K. pneumoniae
resistance
Susceptible
intermediate
Multidrug resistance patterns of ESBL-producing E. coli and K. pneumoniae isolates.
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
| EC ( | ||||||
|
| 7 (63.64) | 4 (36.36) | 0 | AMP, MEM, CTX, CRO, CAZ, CPD, TE | 4 | + |
|
| 5 (45.45) | 6 (54.55) | 0 | AMP, MEM, ATM, CTX, CAZ | 3 | + |
|
| 5 (45.45) | 6 (54.55) | 0 | ATM, CTX, CRO, CAZ, CPD | 2 | – |
|
| 5 (45.45) | 6 (54.55) | 0 | AMP, MEM, CTX, CAZ, TE | 4 | + |
|
| 3 (27.27) | 6 (54.55) | 2 (18.18) | CTX, CRO, CAZ | 1 | – |
| KP ( | ||||||
|
| 2 (18.18) | 8 (72.73) | 1 (9.09) | AMP, CAZ | 2 | – |
|
| 6 (54.55) | 5 (45.45) | 0 | AMP, CN, CTX, CRO, CAZ, CPD | 3 | + |
|
| 3 (27.27) | 8 (72.73) | 0 | AMP, CPD, TE | 3 | + |
|
| 3 (27.27) | 8 (72.73) | 0 | AMP, CN, ATM, | 3 | + |
|
| 3 (27.27) | 7 (63.64) | 1 (9.09) | AMP, CTX, CPD | 2 | – |
|
| 3 (27.27) | 8 (72.73) | 0 | AMP, ATM, CTX | 3 | + |
|
| 3 (27.27) | 8 (72.73) | 0 | AMP, CAZ, CPD | 2 | – |
|
| 2 (18.18) | 9 (81.82) | 0 | AMP, CAZ | 2 | – |
|
| 3 (27.27) | 8 (72.73) | 0 | AMP, CTX, CRO | 2 | – |
Notes.
extended-spectrum β-lactamase
E. coli
K. pneumoniae
resistance
susceptible
intermediate
multidrug resistance
ampicillin
imipenem
meropenem
aztreonam
cefotaxime
ceftriaxone
ceftazidime
cefpodoxime
gentamicin
amikacin
tetracycline
ESBL-encoding genes of E. coli and K. pneumoniae isolates.
|
|
| ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| EC ( | |||||||
|
| + | – | + | -. | + | – | – |
|
| + | + | – | + | – | – | – |
|
| – | + | – | – | – | – | – |
|
| – | + | – | – | – | – | – |
|
| – | + | – | – | – | – | – |
| Total EC | 2 (40) | 4 (80) | 1 (20) | 0 | 0 | ||
| KP ( | |||||||
|
| – | + | – | – | – | – | – |
|
| – | – | – | – | – | – | – |
|
| – | + | – | – | – | – | – |
|
| – | – | – | – | – | – | – |
|
| – | – | – | – | – | – | – |
|
| – | + | – | – | – | – | – |
|
| – | – | – | – | – | – | – |
|
| – | + | – | – | – | – | – |
|
| – | – | – | – | – | – | – |
| Total KP | 0 | 4 (44.44) | 0 | 0 | 0 | 0 | 0 |
| Total EC and KP ( | 2 (14.29) | 8 (57.14) | 1 (7.14) | 0 | 0 | ||
Notes.
extended-spectrum β-lactamase
E. coli
K. pneumoniae
positive
negative
Figure 1A 1.5% (w/v) agarose gel image showing the ESBL-encoding genes amplified from E. coli isolates isolated from vegetables using PCR method.
Lane M = 100 bp DNA Ladder, Lane 1 = TEM gene fragments amplified from E. coli A60301 isolates, Lane 2 = SHV gene fragments amplified from E. coli G3051 isolates, Lane 3 = GES gene fragments amplified from E. coli A6031 isolates, Lane 4 = CTX-M9 gene fragments amplified from E. coli C30501 isolates, Lane 5 = CTX-M1 gene fragments amplified from E. coli A60301 isolates, and Lane NC = Negative control.
Figure 2ERIC-PCR profiles of (A) ESBL-producing E. coli isolates and (B) ESBL-producing K. pneumoniae isolates from raw vegetables.
A dendrogram was generated from the ERIC-PCR typing of five ESBL-producing E. coli and nine K. pneumoniae isolates. The analysis was performed using BioNumerics fingerprint data software v7.1 and the unweighted pair group method with arithmetic means (UPGMA) clustering method and the dice similarity coefficient with 1% optimization and 1.5% position tolerance. EC, E. coli; KP, K. pneumoniae.